Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

Matched clinical trials

  • Study on PET Imaging with Fianlimab and Cemiplimab for Patients with Advanced Solid Tumors, with or without Platinum-Based Chemotherapy

    Recruiting

    1 1 1
    Investigated drugs:
    The Netherlands
  • Study on Reducing Chemotherapy Cycles with Pembrolizumab for Patients with PD-L1-Positive Recurrent or Metastatic Head and Neck Cancer

    Recruiting

    1 1 1
    France
  • Study of petosemtamab compared to standard therapy in previously treated patients with metastatic or recurrent head and neck cancer

    Recruiting

    1 1 1 1
    Belgium Czechia France Germany Greece Hungary +6
  • Study of petosemtamab with pembrolizumab compared to pembrolizumab alone in patients with head and neck cancer who have not received previous treatment for advanced disease

    Recruiting

    1 1 1 1
    Austria Belgium Croatia Czechia France Germany +8
  • Study of Carboplatin, Paclitaxel, and Cetuximab for Patients with Recurrent or Metastatic Head and Neck Cancer After Pembrolizumab Treatment Failure

    Recruiting

    1 1 1
    France
  • Study on Pembrolizumab and Radiotherapy for Patients with Limited Spread of Head and Neck Cancer

    Recruiting

    1 1 1 1
    Investigated drugs:
    Belgium Italy Spain
  • Study on the Effects of Ficlatuzumab and Cetuximab for Adults with Recurrent or Metastatic HPV-Negative Head and Neck Cancer

    Recruiting

    1 1 1
    Investigated drugs:
    Belgium Bulgaria Czechia France Germany Hungary +5
  • Study on Volrustomig, Mycophenolate Mofetil, and Infliximab for Adults with Advanced Head and Neck Cancer Post-Chemoradiotherapy

    Recruiting

    1 1 1 1
    Austria Belgium France Germany Hungary Italy +2
  • Study of Dostarlimab After Chemoradiation for Adults with Advanced Unresected Head and Neck Cancer

    Recruiting

    1 1 1
    Investigated drugs:
    Belgium Czechia France Germany Greece Hungary +7
  • Study of Amivantamab, Pembrolizumab, and Paclitaxel for Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

    Recruiting

    1 1 1
    France Germany Poland Spain